Family screening for a Glanzmann's thrombasthenia mutation using PCR-SSCP

Platelets

Volumn 9, Issue 2, 1998, Pages 129-136

  Ruan, J ^a   Peyruchaud, O ^a   Nurden, P ^a   Cazes, E ^a   Combrie R ^a   Bourre, F ^a   Nurden, A T ^a  

^a HAUT LÉVÊQUE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN IIB; GLYCOPROTEIN IIIA; MESSENGER RNA;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; DONOR SITE; EXON; FEMALE; FRAMESHIFT MUTATION; GENE DELETION; GENE INSERTION; GENE MUTATION; GENE SEQUENCE; GENETIC COUNSELING; GENETIC DISORDER; GENETIC SCREENING; GLANZMANN DISEASE; HETEROZYGOTE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; INTRON; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION MAPPING; SINGLE STRAND CONFORMATION POLYMORPHISM; STOP CODON; THROMBOCYTE;

EID: 0031970750     PISSN: 09537104     EISSN: None     Source Type: Journal    
DOI: 10.1080/09537109876915     Document Type: Article

References (24)

1. George JN, Nurden AT, Phillips DR. Molecular defects in interaction of platelets with the vessel wall. New Engl J Med 1984; 311: 1094-8.
2. George JN, Caen JP, Nurden AT. Glanzmann's thrombasthenia: the spectrum of clinical disease and molecular abnormalities in 64 patients. Blood 1990; 75: 1383-95.
3. French DL, Coller BS. Hematologically important mutations: Glanzmann thrombasthenia. Blood Cells, Mol Dis 1997; 23: 39-51.
4. Coller BS, Seligsohn U, Zivelin A, Zwang E, Lusky A, Modan M. Immunologic and biochemical characterization of homozygous and heterozygous Glanzmann thrombasthenia in the Iraqi-Jewish and Arab populations in Israel: comparison of techniques for carrier detection. Br J Haematol 1986; 62: 723-35.
5. Coller BS, Cheresh DA, Asch E, Seligsohn U. Platelet vitronectin receptor expression differentiates Iraqi-Jewish from Arab patients with Glanzmann's thrombasthenia in Israel. Blood 1991; 77: 75-83.
6. Newman PJ, Seligsohn U, Lyman S, Coller BS. The molecular genetic basis of Glanzmann's thrombasthenia in the Iraqi-Jewish and Arab populations in Israel. Proc Natl Acad Sci USA 1991; 88: 3160-4.
7. Peretz H, Seligsohn U, Zwang E, Coller BS, Newman PJ. Detection of the Glanzmann's thrombasthenia mutations in Arab and Iraqi-Jewish patients by polymerase chain reaction and restriction analysis of blood and urine samples. Thromb Haemostas 1991; 66: 500-4.
8. Coller BS, Seligsohn U, Peretz H, Newman PJ. Glanzmann thrombasthenia: new insights from an historical perspective. Semin Hematol 1994; 31: 301-11.
9. Levy JM, Mayer G, Sacrez R, Ruff R, Francfort J-J, Rodier L. Thrombasthénie de Glanzmann-Naegli. Etude d'un groupe éthnique à forte endogamie. Ann Pediat 1971; 18: 381-9.
10. A1, in type I Glanzmann's thrombasthenia. J Clin Invest 1982; 67: 717-24.
11. IIb gene. Blood 1995; 86: 977-82.
12. De la Salle C, Schwartz A, Baas M-J, Lanza F, Cazenave J-P. Detection by PCR and HphI restriction analysis of a splice site mutation at the 5′ end of intron 15 of the platelet GPIIb (aIIb integrin) gene responsible for Glanzmann's thrombasthenia type I in gypsies originating from the Strasbourg area. Thromb Haemostas 1995; 74: 990-7.
13. Jin Y, Dietz HC, Nurden AT, Bray PF. SSCP is a rapid and effective method for the identification of mutations and polymorphisms in the gene for GPIIIa. Blood 1993; 82: 2281-8.
14. Peyruchaud O, Nurden A, Bourre F. Nonradioactive SSCP for genotyping human platelet alloantigens. Br J Haematol 1995; 89: 633-6.
15. a): genetic determination of a new platelet specific alloantigen on glycoprotein IIIa and its expression in Cos-7 cells. Blood 1997; 89: 2422-8.
16. Nurden P, Savi P, Heilmann E, Bihour C, Herbert J-M. Maffrand J-P, Nurden AT. An inherited bleeding disorder linked to a defective interaction between ADP and its receptor on platelets. J Clin Invest 1995; 95: 1612-22.
17. 3 of platelets and endothelial cells. Eur J Biochem 1994; 222: 743-51.
18. Orita M, Suzuki Y, Sekiya Y, Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 1989; 5: 874-9.
19. b) determinant. Br J Haematol 1995; 91: 747-51.
20. Heidrenreich R, Eisman R, Surrey S, Delgrosso K, Bennet JS, Schwartz E, Ponz M. Organization of the gene for platelet glycoprotein IIb. Biochemistry 1990; 29: 1232-44.
21. McEver RP, Baenziger NL, Majerus PW. Isolation and quantitation of the platelet membrane glycoprotein deficient in thrombasthenia using a monoclonal hybridoma antibody. J Clin Invent 1980; 66: 1311-8.
22. Coller BS, Seligsohn U, Zivelin A, Zwang A, Zwang E, Lusky A, Modan M. Immunologic and biochemical characterization of homozygous and heterozygous Glanzmann thrombasthenia in the Iraqi-Jewish and Arab populations of Israel: comparison of techniques for carrier detection. Br J Haematol 1986; 62: 723-35.
23. Nurden AT, Fournier D, Pidard D. Pathological aspects of platelet aggregation. A consideration of the heterogeneity in Glanzmann's thrombasthenia. In Marguerie G, Zwaal RFA, eds. Biochemistry and Physiopathology of Platelet Membrane. Paris: John Libby Eurotext, 1988: 95-105.
24. Seligsohn U, Milbashan RS, Rodeck CH, Nicolaides KH, Millar DS, Coller BS. Prenatal diagnosis in Glanzmann's thrombasthenia. Lancet 1985; 2: 1419-20.